LOS ANGELES--(EON: Enhanced Online News)--Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Psychemedics Corporation (“Psychemedics” or the “Company”) (Nasdaq: PMD) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between February 28, 2014 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.
“preventing other companies from accessing (the) market.”
If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights free of charge. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at email@example.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
On January 31, 2017, the public was informed that Psychemedics Brasil Exames Toxicologicos Ltda., Psychemedics' local representative in Brazil, was required to compensate Omega Laboratories, Inc. USA for losses arising from anticompetitive practices used for "preventing other companies from accessing (the) market.”
When this information was released to the public, the value of Psychemedics stock fell, causing investors severe harm.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.